How Macrogen Is Democratizing Genomics

BY Frank Pattiasina

Writers Page

Newsweek Is A Trust Project Member

created for

Produced for an organization or individual that has paid for and approved the content.

Copy Link

✓ Link copied to clipboard!

Listen

Translate

English (Original)
Español
中国人
Français
Deutsch
Portuguese
हिन्दी

Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.

Read original

Speed: 0.5xSpeed: 1xSpeed: 1.5xSpeed: 2x

🎙️ Voice is AI-generated. Inconsistencies may occur.

✖

"Every living creature possesses its own genetic blueprint," declared Jacques Monod, French biochemist and 1965 Nobel Prize laureate in Physiology or Medicine. Inspired by this profound insight, Macrogen, established in 1997, has emerged as a global pioneer in genome sequencing and testing, pushing the boundaries of what is possible with our DNA. With a mission to democratize access to genomic information, Macrogen has launched its latest initiative, GenTok. This innovative platform aims to provide affordable and precise genetic services to over 10 million people worldwide within the next five years.

"Right now, we are focusing on shifting from treatment to prevention and expanding the use of genetic analysis," says Macrogen Chairman Jeong-Sun Seo. By analyzing both genetic and microbiome data, GenTok offers a holistic approach to wellness, further enhanced with an AI-powered chatbot that delivers highly personalized health consultations. The platform not only transforms how individuals use their personal genome but also serves as an educational tool, empowering users to make informed lifestyle choices and proactively manage their well-being.

Jeong-Sun Seo

Jeong-Sun Seo, Chairman, Macrogen Inc. Credit: Courtesy of Macrogen Co., Ltd. Jeong-Sun Seo, Chairman, Macrogen Inc. Credit: Courtesy of Macrogen Co., Ltd.

GenTok offers an opportunity to experience genetic testing in a way that is engaging and educational.

Jeong-Sun Seo, Chairman, Macrogen Inc.

Initially developed for doctors and medical institutions, GenTok utilizes DNA testing to help health care professionals prescribe medications tailored to personal genome profiling. This personalized approach improves treatment outcomes, shortens recovery times, and reduces costs for health care systems. "Macrogen's GenTok offers an opportunity to experience genetic testing in a way that is engaging and educational," explains Seo. Beyond health care, GenTok resonates with younger generations who are less focused on diseases and more interested in self-discovery.

Another significant contribution is the GenTok Biome service that "analyzes 11 wellness indicators like bloating, happiness, sleep and immunity, as well as 14 nutrient metabolism scores and 19 probiotics approved by the Ministry of Food and Drug Safety," says Seo. Accessible through the GenTok app, users can manage their health from home based on their gut environment, which evolves with lifestyle and habits. With plans to expand into regular monitoring and specialized microbiome analyses, and bolstered by Ubiome's intellectual property, Macrogen is poised to lead a microbiome market projected to grow to $10.09 billion by 2026.

1 of 2

8Macrogen-4

GenTok (DNA Testing). Credit: Courtesy of Macrogen Co., Ltd.

8Macrogen-4

GenTok (DNA Testing). Credit: Courtesy of Macrogen Co., Ltd.

8Macrogen-5

The Biome (Microbiome Testing). Credit: Courtesy of Macrogen Co., Ltd.

Driving this innovation is Macrogen's unwavering commitment to staying at the technological forefront. Often the first in Asia–and sometimes in the world—to adopt groundbreaking tools such as NovaSeq X, Revio and UG100, Macogen integrates top-tier equipment at its Korea HQ and extends these advancements to affiliates across Japan, APAC, Europe, the U.S. and Latin America. Leveraging ultra-precise genome analysis tools from Illumina and PacBio's long-read sequencing technology enables Macrogen to decode complex DNA sequences, providing deep insight into structural variations and gene rearrangements.

Building on its technological leadership, Macrogen is anchoring its global strategy with the Songdo Global Campus, an 18,800-square-meter facility set to become Asia's largest genome big data hub by 2026. This genome foundry will integrate genome data with AI, streamlining the entire genome business value chain and driving digital health care transformation. Beyond Songdo, Macrogen is expanding its global reach. In Europe, the company's "Genome Supermarkets" span key markets like Belgium, Italy, France and Germany, with plans to expand into Madrid and the U.S. market. With partnerships across 160 countries and over 20,000 research institutions, Macrogen is also tailoring solutions to local needs in Latin America, the Middle East, Southeast Asia and Oceania, driving progress in genome technologies through collaboration and localized strategies.

1 of 2

8Macrogen-3

Macrogen Songdo Global Campus. Credit: Courtesy of Macrogen Co., Ltd.

8Macrogen-3

Macrogen Songdo Global Campus. Credit: Courtesy of Macrogen Co., Ltd.

8Macrogen-2

Global Network Map. Credit: Courtesy of Macrogen Co., Ltd.

Macrogen's vision reaches far beyond the present, aiming to unlock the full potential of genomics for the benefit of humanity. "We see genetic blueprints as a kind of GPS navigator, guiding future advancements," shares Seo. The company's ultimate goal is to make DNA testing available to people everywhere, empowering them to lead healthier, more fulfilling lives. Beyond this, the chairman dreams of using genome sequencing to address profound scientific mysteries and unanswered questions. With its bold ambitions and innovative strategies, Macrogen is charting a course toward a future where precision medicine and genome sequencing are within reach for all.

For more details, explore the website at: https://www.macrogen.com/en/main

All interviews were conducted by The Worldfolio and can be found at www.theworldfolio.com.

This article has been paid for by a third party. The views and opinions expressed are not those of Newsweek and are not an endorsement of the products, services or persons mentioned.